Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease

Martine Aardoom; MME Jongsma; AC Vries; J Wolthoorn; Lissy de Ridder; Hankje Escher

doi:10.1097/MPG.0000000000002833

Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease

Martine Aardoom, MME Jongsma, AC Vries, J Wolthoorn, Lissy de Ridder, Hankje Escher

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

23 Downloads (Pure)

Original language	English
Pages (from-to)	501-507
Number of pages	7
Journal	Journal of Pediatric Gastroenterology and Nutrition
Volume	71
Issue number	4
DOIs	https://doi.org/10.1097/MPG.0000000000002833
Publication status	Published - 2020

Research programs

EMC MM-04-54-07

Access to Document

10.1097/MPG.0000000000002833

Repub_130751.pdfFinal published version, 467 KB

http://hdl.handle.net/1765/130751

Cite this

@article{822f59e9196145c4b143cbe8e0eba5bf,

title = "Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease",

author = "Martine Aardoom and MME Jongsma and AC Vries and J Wolthoorn and {de Ridder}, Lissy and Hankje Escher",

year = "2020",

doi = "10.1097/MPG.0000000000002833",

language = "English",

volume = "71",

pages = "501--507",

journal = "Journal of Pediatric Gastroenterology and Nutrition",

issn = "0277-2116",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

TY - JOUR

T1 - Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease

AU - Aardoom, Martine

AU - Jongsma, MME

AU - Vries, AC

AU - Wolthoorn, J

AU - de Ridder, Lissy

AU - Escher, Hankje

PY - 2020

Y1 - 2020

U2 - 10.1097/MPG.0000000000002833

DO - 10.1097/MPG.0000000000002833

M3 - Article

C2 - 32639455

SN - 0277-2116

VL - 71

SP - 501

EP - 507

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

IS - 4

ER -